Davidson Kempner Capital Management’s Pfizer PFE Stock Holding History

Davidson Kempner Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-158,100	Closed	-$5.04M	–	205
2017 Q2	$5.04M	Buy	+158,100	New	+$4.99M	0.07%	130
2014 Q4	–	Sell	-1,892,268	Closed	-$53.1M	–	161
2014 Q3	$53.1M	Hold	1,892,268	–	–	1.21%	15
2014 Q2	$53.3M	Hold	1,892,268	–	–	1.58%	13
2014 Q1	$57.7M	Hold	1,892,268	–	–	2.1%	11
2013 Q4	$55M	Hold	1,892,268	–	–	1.98%	10
2013 Q3	$51.6M	Hold	1,892,268	–	–	1.71%	10
2013 Q2	$50.3M	Buy	+1,892,268	New	+$52.3M	2.52%	11

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Davidson Kempner Capital Management's PFE Position: Q3 2017 in Review

Davidson Kempner Capital Management sold out of Pfizer (PFE) in Q3 2017, closing a stake of 158,100 shares — an estimated $5.04M sold.

Davidson Kempner Capital Management first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $57.7M in Q1 2014. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

Davidson Kempner Capital Management reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
Davidson Kempner Capital Management sold 158,100 Pfizer shares in Q3 2017, an estimated $5.04M.
Davidson Kempner Capital Management first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
Davidson Kempner Capital Management's Pfizer position peaked at $57.7M in Q1 2014.
2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Davidson Kempner Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.